Search Results - "Botker, H. E."

Remote ischaemic conditioning: defining critical criteria for success—report from the 11th Hatter Cardiovascular Workshop by Bell, R. M., Basalay, M., Bøtker, H. E., Beikoghli Kalkhoran, S., Carr, R. D., Cunningham, J., Davidson, S. M., England, T. J., Giesz, S., Ghosh, A. K., Golforoush, P., Gourine, A. V., Hausenloy, D. J., Heusch, G., Ibanez, B., Kleinbongard, P., Lecour, S., Lukhna, K., Ntsekhe, M., Ovize, M., Salama, A. D., Vilahur, G., Walker, J. M., Yellon, D. M.

“…The Hatter Cardiovascular Institute biennial workshop, originally scheduled for April 2020 but postponed for 2 years due to the Covid pandemic, was organised…”
Get full text

Diagnosing coronary artery disease after a positive coronary computed tomography angiography: the Dan-NICAD open label, parallel, head to head, randomized controlled diagnostic accuracy trial of cardiovascular magnetic resonance and myocardial perfusion scintigraphy by Nissen, L, Winther, S, Westra, J, Ejlersen, J A, Isaksen, C, Rossi, A, Holm, N R, Urbonaviciene, G, Gormsen, L C, Madsen, L H, Christiansen, E H, Maeng, M, Knudsen, L L, Frost, L, Brix, L, Bøtker, H E, Petersen, S E, Bøttcher, M

“…Abstract Aims Perfusion scans after coronary computed tomography angiography (CCTA) in patients with suspected coronary artery disease (CAD) may reduce…”
Get full text

Virtual Histology Assessment of Cardiac Allograft Vasculopathy Following Introduction of Everolimus—Results of a Multicenter Trial by Arora, S., Erikstad, I., Ueland, T., Sigurdardottir, V., Ekmehag, B., Jansson, K., Eiskjær, H., Bøtker, H. E., Mortensen, S.‐A., Saunamaki, K., Gude, E., Ragnarsson, A., Solbu, D., Aukrust, P., Gullestad, L.

“…In this 12‐month multicenter Scandinavian study, 78 maintenance heart transplant (HTx) recipients randomized to everolimus with reduced calcineurin inhibitor…”
Get full text

ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies by Lecour, Sandrine, Bøtker, Hans E, Condorelli, Gianluigi, Davidson, Sean M, Garcia-Dorado, David, Engel, Felix B, Ferdinandy, Peter, Heusch, Gerd, Madonna, Rosalinda, Ovize, Michel, Ruiz-Meana, Marisol, Schulz, Rainer, Sluijter, Joost P G, Van Laake, Linda W, Yellon, Derek M, Hausenloy, Derek J

“…Ischaemic heart disease (IHD) remains the leading cause of death and disability worldwide. As a result, novel therapies are still needed to protect the heart…”
Get full text

9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection by Bell, R. M., Bøtker, H. E., Carr, R. D., Davidson, S. M., Downey, J. M., Dutka, D. P., Heusch, G., Ibanez, B., Macallister, R., Stoppe, C., Ovize, M., Redington, A., Walker, J. M., Yellon, D. M.

“…In the 30 years since the original description of ischaemic preconditioning, understanding of the pathophysiology of ischaemia/reperfusion injury and concepts…”
Get full text

The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One‐Year Results of a Scandinavian Randomized Trial by Arora, S., Andreassen, A. K., Andersson, B., Gustafsson, F., Eiskjær, H., Bøtker, H. E., Rådegran, G., Gude, E., Ioanes, D., Solbu, D., Sigurdardottir, V., Dellgren, G., Erikstad, I., Solberg, O. G., Ueland, T., Aukrust, P., Gullestad, L.

“…Early initiation of everolimus with calcineurin inhibitor therapy has been shown to reduce the progression of cardiac allograft vasculopathy (CAV) in de novo…”
Get full text

Exenatide Alters Myocardial Glucose Transport and Uptake Depending on Insulin Resistance and Increases Myocardial Blood Flow in Patients with Type 2 Diabetes by Gejl, M, Søndergaard, H. M, Stecher, C, Bibby, B. M, Møller, N, Bøtker, H. E, Hansen, S. B, Gjedde, A, Rungby, J, Brock, B

“…Context: Glucagon-like peptide-1 (GLP-1) and GLP-1 receptor agonists provide beneficial cardiovascular effects by protecting against ischemia and reperfusion…”
Get full text

Repeated Contrast Administration Is Associated With Low Risk of Postcontrast Acute Kidney Injury and Long‐Term Complications in Patients With Severe Chronic Kidney Disease by Winther, S., Svensson, M., Jørgensen, H. S., Birn, H., Bøtker, H. E., Ivarsen, P., Bøttcher, M.

“…Patients with chronic kidney disease (CKD) frequently require radiographic examinations. We investigated the impact of repeated contrast administrations on…”
Get full text

Metabolic fingerprint of ischaemic cardioprotection: importance of the malate-aspartate shuttle by Nielsen, Torsten Toftegaard, Støttrup, Nicolaj Brejnholt, Løfgren, Bo, Bøtker, Hans Erik

“…The convergence of cardioprotective intracellular signalling pathways to modulate mitochondrial function as an end-target of cytoprotective stimuli is well…”
Get full text

Preadmission use of ACE inhibitors or angiotensin receptor blockers and short-term mortality after stroke by Sundbøll, J, Schmidt, M, Horváth-Puhó, E, Christiansen, CF, Pedersen, L, Bøtker, HE, Sørensen, HT

“…Background and aimThe prognostic impact of ACE inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs) on stroke mortality remains unclear. We aimed to…”
Get full text

Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation by Schmidt, M., Johansen, M. B., Robertson, D. J., Maeng, M., Kaltoft, A., Jensen, L. O., Tilsted, H.-H., Bøtker, H. E., Sørensen, H. T., Baron, J. A.

“…Aliment Pharmacol Ther 2012; 35: 165–174 Summary Background  Cytochrome P450 inhibition by proton pump inhibitors (PPIs) may attenuate the effectiveness of…”
Get full text

Exercise-induced cardioprotection is mediated by a bloodborne, transferable factor by Michelsen, M. M., Støttrup, N. B., Schmidt, M. R., Løfgren, B., Jensen, R. V., Tropak, M., St-Michel, E. Jean, Redington, A. N., Bøtker, H. E.

“…Exercise protects against myocardial ischemia-reperfusion (I-R) injury but the mechanism remains unclear. Protection can be transferred from a remotely…”
Get full text

Organ-specific responses during brain death: increased aerobic metabolism in the liver and anaerobic metabolism with decreased perfusion in the kidneys by Van Erp, A. C., Rebolledo, R. A., Hoeksma, D., Jespersen, N. R., Ottens, P. J., Nørregaard, R., Pedersen, M., Laustsen, C., Burgerhof, J. G. M., Wolters, J. C., Ciapaite, J., Bøtker, H. E., Leuvenink, H. G. D., Jespersen, B.

“…Hepatic and renal energy status prior to transplantation correlates with graft survival. However, effects of brain death (BD) on organ-specific energy status…”
Get full text

Inhibition of KV7 Channels Protects the Rat Heart against Myocardial Ischemia and Reperfusion Injury by Hedegaard, Elise R, Johnsen, Jacob, Povlsen, Jonas A, Jespersen, Nichlas R, Shanmuganathan, Jeffrey A, Laursen, Mia R, Kristiansen, Steen B, Simonsen, Ulf, Bøtker, Hans Erik

“…The voltage-gated KV7 (KCNQ) potassium channels are activated by ischemia and involved in hypoxic vasodilatation. We investigated the effect of KV7 channel…”
Get more information

Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia–reperfusion injury in humans by PEDERSEN, C. M., CRUDEN, N. L., SCHMIDT, M. R., LAU, C., BØTKER, H. E., KHARBANDA, R. K., NEWBY, D. E.

Get full text

Influence of Cardiac CT based disease severity and clinical symptoms on the diagnostic performance of myocardial perfusion by Nissen, L., Winther, S., Westra, J., Ejlersen, J. A., Isaksen, C., Rossi, A., Holm, N. R., Urbonaviciene, G., Gormsen, L. C., Madsen, L. H., Christiansen, E. H., Maeng, M., Knudsen, L. L., Frost, L., Brix, L., Bøtker, H. E., Petersen, S. E., Bøttcher, M.

“…We aimed to identify factors influencing the sensitivity of perfusion imaging after an initial positive coronary computed tomography angiography (CCTA) using…”
Get full text

Percutaneous coronary intervention in diabetic patients: a problem? by Nielsen, T T, Bøtker, H E

“…Pharmacological and technological advances in surgical and interventional coronary treatment modalities have shown reduced cardiovascular mortality in…”
Get more information

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA) by Kristensen, Steen Dalby, Knuuti, Juhani, Saraste, Antti, Anker, Stefan, Bøtker, Hans Erik, De Hert, Stefan, Ford, Ian, Gonzalez Juanatey, Jose Ramón, Gorenek, Bulent, Heyndrickx, Guy Robert, Hoeft, Andreas, Huber, Kurt, Iung, Bernard, Kjeldsen, Keld Per, Longrois, Dan, Luescher, Thomas F, Pierard, Luc, Pocock, Stuart, Price, Susanna, Roffi, Marco, Sirnes, Per Anton, Uva, Miguel Sousa, Voudris, Vasilis, Funck-Brentano, Christian

Get full text

Ischaemic preconditioning does not protect the heart in obese and lean animal models of Type 2 diabetes by KRISTIANSEN, S. B, LØFGREN, B, STØTTRUP, N. B, KHATIR, D, NIELSEN-KUDSK, J. E, NIELSEN, T. T, BØTKER, H. E, FLYVBJERS, A

“…The prevalence of type 2 diabetes mellitus is increasing worldwide with obese diabetic patients constituting the majority of this population. Type 2 diabetes…”
Get full text

Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure by NØRRELUND, H., WIGGERS, H., HALBIRK, M., FRYSTYK, J., FLYVBJERG, A., BØTKER, H. E., SCHMITZ, O., JØRGENSEN, J. O. L., CHRISTIANSEN, J. S., MØLLER, N.

“… Objective.  It is well known that chronic heart failure (CHF) is associated with insulin resistance and cachexia, but little is known about the underlying…”
Get full text